Clinical trial
Treatment With Intent to Generate Endovascular Reperfusion
NCT03474549 is registered in ClinicalTrials.gov with Rapid Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment With Intent to Generate Endovascular Reperfusion
- Lead sponsor
- Rapid Medical
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 9, 2018
- Completion date
- June 30, 2020
- Enrollment
- 160 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.